This review comprehensively summarizes the expression patterns of CD39, CD73, and CD38 in CTCL (Figure 3), providing new insights for the diagnosis, prognosis, and treatment of aggressive CTCL including SS. Here, NT5E is linked to primary cutaneous T-cell non-Hodgkin lymphoma.